![](https://media.americanpharmaceuticalreview.com/m/28/article/614219.jpg)
Precigen Appoints Chief Commercial Officer to Spearhead First Potential Gene Therapy Launch
Precigen, Inc. , a biopharmaceutical company specializing in the development of gene and cell therapies, announced the appointment of Phil Tennant as the Company's chief commercial officer. Mr. Tennant will be responsible for commercial strategy and …